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Abstract—Uniform heating of tumor tissue to therapeutic temperatures without damaging 
surrounding normal tissue is required for optimal local heat therapy of cancer. This paper 
describes an algorithm for online computer control that will allow the therapist to minimize the 
standard deviation of measured intratumoral temperatures. The method is applicable to systems 
incorporating multiple surface and/or interstitial applicators delivering microwave, 
radiofrequency, or ultrasonic power and operating under the control of a small computer. The 
essential element is a novel predictive-adaptive control algorithm that infers relevant thermal 
parameters from the responses of multiple temperature sensors, as each of the power applicators 
is briefly turned off. Applied power and effective perfusion are estimated from transient slope 
changes of the temperature-time curves for each sensor. By substituting these values into a 
system of linear equations derived from the bio-heat transfer equation, the small computer can 
calculate the optimal allocation of power among the various applicators (“knob settings”) to 
generate most uniform intratumoral temperature distribution with the desired mean, or minimum, 
tumor temperature. 
 











i = l, 2, 3,. k denote external or interstitial applicators, each at a fixed position in space. 
 
j = l, 2, 3,..n denote points in the tumor at which temperature, applied power density, and 





j,iP  estimated power density (SAR) that would be generated at point j, assuming all power is 
delivered via applicator i. 
 
i  fraction of total power delivered through applicator. 
 







j  apparent perfusion (SCR) at point j calculated from thermal washout. 
 
t diagnostic cycle time. 
 





jT  temperature rise above arterial temperature at measuring point j at beginning of next 
diagnostic cycle = end of current diagnostic cycle. 
 
j )c/(tc5.0 bj  , a dimensionless dummy variable related to heat loss during the 
diagnostic cycle. 
 
di,j   )1(P)c/(t jj,i  , a dummy variable with units of temperature.  
 









id  mean value of di,j for all points j = 1 to n, a dummy variable associated with each 
applicator. 
 
r power multiplier; total power required to achieve target temperature at end of next 






During local heat therapy for a circumscribed tumor mass, the therapist strives to elevate 
intratumoral temperature uniformly to a therapeutic, tumor killing level while maintaining 
surrounding normal tissue at a safe, nonlethal temperature. In the ideal limiting case, the 
temperature distribution in space would approach a step function, abruptly rising to a constant 
therapeutic level at the tumor edge (Fig. 1). It is useful to describe such an ideal temperature 
distribution as having two essential properties: 
 
(1) A clear separation of the mean intratumoral temperature from the mean temperature of 
surrounding normal tissue during treatment. 
 
(2) Minimum spatial variation in intratumoral temperatures.  
 
The first property describes selectivity of heating; the second property describes uniformity of 
heating. 
 
An effective biological means for enhancing the selectivity of local heat treatment is through the 
use of vasodilator drugs, which favorably alter the partitioning of blood flow between tumor and 
surrounding normal tissue [1]-[3]. Complementary technological means of enhancing selectivity 
include schemes for focusing power deposition within the tumor mass, such as multiple 







Fig. 1. Concept of ideal local heat therapy for a circumscribed lesion. Tumor temperature is 
uniformly elevated with respect to surrounding normal tissue. The variability of intratumoral 
temperatures is nil. 
  
 
There remains, however, the problem of achieving maximal uniformity of tumor temperatures. 
Some method is needed to adjust power in the multiple applicators to avoid treatment failures 
associated with cold spots in the tumor, as well as possible complications associated with hot 
spots within the treatment field. The present paper describes a predictive-adaptive control 
algorithm that enhances the uniformity of intratumoral temperature distributions by favorably 
adjusting and continually readjusting the proportion of power applied to various surface and/or 
interstitial applicators during the course of a treatment session. 
 
 
II. COMPUTATIONAL METHODS 
 
The computational approach we present for predictive-adaptive, multipoint feedback control of 
multi-applicator hyperthermia systems has three major aspects. The first is the means by which a 
microcomputer can estimate applied power density and “effective perfusion” from temperature 
data recorded from each of several temperature probes embedded in the tissue. The second is the 
means by which the computer can repeatedly calculate the optimal partitioning of total power 
among the various applicators by solving a set of simultaneous, linear equations. The third is the 
means by which total power is then scaled to achieve the desired mean (or minimum) 




A. Real-Time Estimation of Thermal Parameters  
 
Previous reports have described the well-known technique in which, assuming that initial tissue 
temperature is stable and equal to arterial blood temperature, specific absorption rate (SAR) of 
applied energy (i.e., power) can be estimated from the slope of the temperature-time curve 




where    is tissue density, c  is tissue specific heat,  T  is temperature, and  t  is time [1], [7]. It is 
equally true, however, from inspection of the bio-heat equation, that if at any time during tissue 
heating power is suddenly turned off, the SAR just prior to turn-off must be equal to the resultant 
slope change, i.e., 
 
 
A hyperthermia treatment usually lasts 30 to 60 min. The time required to monitor slope changes 
after power-off is roughly 30 sec, an interval typically short with respect to thermal time 
constants in tissue. The specific contribution of each applicator to the net SAR can be obtained 
by analysis of the effect upon temperature at each monitored location caused by turning the 
power to the applicator off for about 30 sec. In a similar way, “effective perfusion” or “specific 
cooling rate” (SCR) can be determined from the slope of the temperature-time curves at each 




where  cb  is the blood specific heat and  T  is the tissue temperature rise above arterial 
temperature. We refer to the process of measuring the power contribution of each applicator and 
the effective perfusion at each site as a diagnostic cycle. Since the distribution of perfusion 
(typically the dominant component of SCR) in adjacent normal tissues changes during the 
hyperthermia treatment, and since power will be deliberately changed under computer control, it 
is necessary to repeat the diagnostic cycle continually to obtain updated values. In this way, the 
essential heat transfer parameters for predictive control of the temperature distribution can be 




B. Computation of Power Fractionation for Minimal Standard Deviation of Measured 
Intratumoral Temperatures 
 
The mathematical approach we propose for computation of the optimal power fractionation from 
the set of estimated SAR and SCR data at each monitored intratumoral site is based upon the 
concept that the net SAR from multiple applicators is a linear combination of the contributions to 
SAR generated by the individual applicators, which are in turn proportional to the fraction, , of 
the total power allocated to each. That is, we assume an incoherent mode of incident power, in 
which effects of phase addition and cancellation can be ignored. It is possible, then, to write an 
expression for the variance of the intratumoral temperatures (mean squared deviation about the 
mean temperature) as a function of the u values. We wish to know the rr values that minimize 
this variance. By differentiating the expression for the variance with respect to each u value and 
setting the partial derivatives equal to zero, we shall obtain a set of simultaneous linear equations 
that can be solved for the unique set of    values giving minimum intratumoral temperature 
variation. The derivation is as follows. 
 
Consider, in particular, a situation in which a tumor is heated by  k  different applicators 
arranged in and around the tumor mass, as sketched in Fig. 2. Let the relevant variables be 




Fig. 2. General scheme of multi-applicator hyperthermia treatment assumed in derivation. The 












Here the first subscript of P represents an applicator from 1 to k and the second subscript of P 
represents a point of intratumoral temperature measurement from 1 to n. Recall that Pi,j 
represents the SAR at point  j  if 100 percent of the applied power were delivered continuously 
via applicator, i. It is obtained from the change in slope of the temperature time function at point  
j  as power to applicator  i  is briefly interrupted, divided by the current value of i. Now 




where T= temperature rise above arterial temperature. Letting T0 represent the current 









Passing to the integral as a representation of the sum, and using the trapezoidal rule to 










Now substituting the cycle time t = m dt, and solving for the temperature rise Tj at the end of 







is a dimensionless indicator of effective perfusion. Now, for simplicity, letting the doubly 














This is an expression for estimated temperature at the end of the next diagnostic cycle as a 
function of the prevailing applied power, effective perfusion, and partitioning of applied power 




for points  1  to  n  within the tumor is minimized, i.e., to choose the    values for most uniform 
heating. Because their sum must equal 1, only k – 1 of the     values may be specified 
independently. 
 



































There are k – 1 such equations and k – 1 unknown o values corresponding to the indices i = 1 to 
k – 1. This terminology can be simplified by writing the above as 
 
 







with  i  referring to the applicator number and  j  referring to the point number. The entire set of  i  











The solution of these linear equations defining the optimal    values can be easily done by a 
commercial microcomputer in conjunction with software that computes and stores SAR and SCR 
values. Such a task, as opposed to tasks requiring clinical judgment and knowledge of anatomy 
and patient geometry, is appropriately accomplished by a digital computer. 
 
 
C. Computation of Optimal Total Power 
 
Knowing the optimal set of    values, it is then straightforward to compute the recommended 
total applied power required to achieve a user-specified mean or minimal target temperature. 
This may be done by several methods. A simple and effective strategy that takes advantage of 
knowledge of thermal parameters is as follows. Suppose that we find the    values for minimal 
standard deviation using the current value of total applied power. The mean estimated 







If the new total power is  r  times the current power, partitioned according to the previously 








Thus, we can select the value of  r  to give the desired mean temperature at the end of the next 
diagnostic cycle, which at the same time has minimal standard deviation. The applied power 
levels or “control knob settings” for each applicator are then multiplied by (new  old) r to 
14 
 
obtain the revised power settings predicted to generate a measured intratumoral temperature 
distribution that has both minimal standard deviation and on-target mean temperature. If the 
therapist prefers to define the target in terms of the minimal sensed intratumoral temperature, 
then a similar process can be followed, in which the smallest predicted tumor temperature at the 
end of the next diagnostic cycle is substituted for mean temperature. 
 
 
III. SIMULATIONS OF CONTROLLER PERFORMANCE 
 
We have simulated this proposed control procedure on a mainframe computer, using one 
program that solves a one-dimensional version of the bio-heat equation [8] to simulate 
temperature changes in tissue and another program that implements the online control algorithm. 
Although compiled together, the two programs are logically independent, so that a real 
thermometry system and patient or phantom can be substituted for the bio-heat equation model 
with only trivial changes to the control software. 
 
A simplified version of the control algorithm is presented in Fig. 3. The program first reads 
treatment specifications from a disk file, including such information as the target temperature, 
the number of power applicators, and the location of temperature probes (whether in tumor or 
normal tissue). Initial conditions of the thermal model are then read from a separate file. Then 
the control program loops through diagnostic and power update cycles, as long as the prescribed 
treatment time has not elapsed. During a diagnostic cycle, power to each of the multiple 
applicators is sequentially turned off for a brief period (e.g., 20 sec). The contribution of each 
applicator to net SAR and the effective perfusion at each monitored site are then computed from 
slope changes.  
 
In the current implementation, the slope change at a given monitoring site that would occur when 
all applicators are turned off is estimated from the sum of slope changes that occur when each 
applicator is turned off separately. This feature shortens the diagnostic cycle and eliminates large 
dips in temperature associated with total power-off for many configurations.  
 
The computer then calculates the set of  values, defining the unique partitioning of the current 
total power that minimizes the standard deviation of predicted intratumoral temperatures at the 
end of the next diagnostic cycle. The result is a set of revised “knob settings” that indicate new 
values of power to be applied to each applicator.  
 
Next, the control program computes the scale factor, r, required for mean (or if desired, 
minimum) intratumoral temperature to equal the target. After a safety check to make sure the 
revised knob settings are not excessive, the control software closes the loop by adjusting power 
of the modeled applicators to the new knob settings, writes diagnostic information to a record 








Fig. 3. Simplified version of the control algorithm. For explanation, see text. 
 
 
First we tested how the system works in simulation for a simple example, in which the correct 
solution is intuitively obvious. In this case, two applicators deposit power uniformly in two 
bands of tumor tissue located at different depths far from the skin surface. One temperature 
sensor is located in the middle of each band (Fig. 4). Blood flow to the tissue is uniform and 
constant. Because slope-taking algorithms are known to be sensitive to noise, we added a 
subroutine to the bio-heat equation model to generate random noise ( 0.05 oC) and then round 
off temperatures to the nearest 0.1 
o
C as a provocative test of the control algorithm. Such noise 







Fig. 4. Sketch of the computational model used in initial tests of algorithm performance. Two 
bands of tissue are uniformly irradiated. One temperature sensor is located in the middle of each 
band. Bands are 3.0 cm wide and separated by 3.0 cm in the calculations. 
 
 
Fig 5, The performance of a control algorithm in simulation, Blood flow is uniform and constant: 
200 ml/min/kg. Initial power partitioning was 150 W/kg to band A (solid line) and 50 W/kg to 
band B (dashed line) The power-off interval was 30 sec. Temperatures were sampled every 2 
sec. Optimal solution requires that the two temperatures are equal to each other and equal to the 
target, here 44 °C. Steady-state portioning of power was 49.9 percent in band A and 50.1 percent 




For this simple case, the optimal solution is one in which power is equally partitioned between 
the two bands so that the temperature at each sensor is on-target and the standard deviation of 
measured temperatures is zero, i.e., the two temperatures are equal to each other and equal to the 
target temperature, here 44 
o
C. The simulation shown in Fig. 5 was begun with unequal powers, 
as indicated by the initial slopes: 75 percent (150 W/kg) to band A and 25 percent (50 W/kg) to 
band B. After the first diagnostic cycle, the system adjusts power to both applicators and the 
temperatures head toward the target. After two diagnostic cycles, the temperatures settle very 
near the target. The percentage of total applied power in each band then fluctuates between 49 
and 51 percent, very near the correct solution. For comparison, Fig. 6 presents temperature-time 
curves for exactly the same situation with the control algorithm turned off. Note that steady-state 





Fig. 6. Control simulation for Fig. 5. Conditions identical to Fig. 5 with the control algorithm 
turned off. Deliberately introduced noise in the temperature data is evident.  The vertical sale 






Fig. 7. Algorithm performance with temperature dependent augmentation of blood flow. In this 
simulation, the thermal model updated perfusion as a function of temperature in a linear fashion 
up to six-fold over the temperature range from 41 to 46 
o
C. The power-off interval was 12 sec. 
Temperatures were sampled every 2 sec. Despite increased perfusion, the algorithm is able to 
encourage tissue temperatures toward the target level of 44 
o
C. Solid line = band A; dashed line 
= band B. Steady-state partitioning of power was 48.4 percent in band A, 51.6 percent in band B. 
 
 
Performance with Variable Blood Flow: In the previous example, blood flow to the tissue was 
kept constant. To illustrate the performance of the control algorithm in the presence of changing 
blood flow, Fig. 7 is presented. Now the thermal model updates tissue perfusion as a function of 
temperature according to a simplified linear approximation to Song’s results [9], [10]: a six-fold 
increase in blood flow over the temperature range from 41 to 46 
o
C. Note that despite increased 
perfusion, the algorithm is able to encourage tissue temperatures toward the target level of 44 
o
C. 
In Fig. 8, the same simulation is repeated with the control algorithm disabled. The temperatures 







Fig. 8. Control simulation for Fig 7. Conditions identical to Fig. 7 with the control algorithm 
turned off. The temperatures are divergent and off-target. Deliberately introduced noise is 
evident. 
 
These preliminary results with a one-dimensional computational model of heated tissue serve to 
illustrate the satisfactory performance of the algorithm in the presence of noise, round-off errors, 
and variable blood flow. They give us encouragement to pursue development and elaboration of 







A major improvement in hyperthermia can be expected if spatial temperature distributions could 
be achieved similar to that depicted in Fig. 1: The present approach implements an algorithm to 
minimize the standard deviation of measured intratumoral temperatures, and in turn, to adjust 





Fig. 9. Concept of present versus improved hyperthermia illustrated with histograms. Wide 
variation in intratumoral temperatures leads to hot spots and cold spots (a). In an attempt to 
minimize complications associated with hot spots, total power is limited such that mean 
temperature is less than the target temperature. In improved hyperthermia with multipoint 
feedback control, the standard deviation of intratumoral temperatures is reduced, and mean 




Dewhirst, Sire, and coworkers have shown a strong correlation between high variability in 
intratumoral temperature and poor outcome of clinical hyperthermia treatment of spontaneous 
cancers in pet animals [11]. In essence, they found that if the distribution of temperatures within 
a tumor shows significant dispersion about its mean value, treatment failures and complications 
are likely to result. Cold spots never reach therapeutic temperatures, and so are never treated. Hot 
spots lead to complications such as intolerable pain or ulceration of overlying skin. To avoid 
complications of hot spots, the therapist is obliged to reduce total applied power, and as a result, 
mean tumor temperature is often below target (Fig. 9(a)). 
 
The predictive-adaptive control algorithm described in this paper can make for more uniform 
tumor heating, correct for heat-induced changes in blood flow, and permit improved heat therapy 
without the moment-to-moment attendance of a physicist, once applicators and temperature 
sensors have been correctly placed and the treatment started. Because its implementation is 
substantially dependent upon software rather than hardware, the proposed control scheme can 
provide great marginal benefit at little marginal cost. Treatment planning is done automatically 
under computer control during the course of actual therapy. Changes in blood flow due to heat-
induced vasodilation in normal tissues, shunting of flow from tumor to normal tissues, and 
perfusion changes due to thermal damage to capillaries and/or microvascular coagulation are 
accounted for on a moment-to-moment basis. Formulation of such a dynamic treatment plan 
lends itself to computer assistance and control since computer based systems can easily conduct 
regular moment-to-moment monitoring of thermal data as well as rapid analysis, calculation, and 
adjustment of input power levels. 
 
It is important to point out at this juncture that the system just demonstrated is fundamentally 
more sophisticated than one in which total power is servo-controlled to maintain the temperature 
of a single sensor at a target level. This latter type of system is quite inadequate for solving the 
uniformity problem. Although temperature at a single point in the tumor may be reliably kept on 
target, there is no guarantee that cold spots do not exist elsewhere in the tumor, and in particular, 
no guarantee that edge temperatures will be sufficient. Our system optimizes not a single 
temperature, but the entire sensed temperature distribution. Although more complex than 
classical controllers, the present algorithm does not require estimation of the entire three 
dimensional temperature distribution. Rather, the controller deals only with temperatures at 
measured sites. 
 
Computation time is much less than is required to solve a finite element model: in our experience 
to date, a few seconds when performed on an IBM-PC. In principle, it should not be necessary 
for the therapist to enter a description of the geometry, location, and extent of the tumor and 
surrounding normal tissues, only to identify temperature sensors as being in normal or tumor 
tissue. Multipoint thermometry and multiple applicators are required, however, and the greater 
the number of each, the more ideal the control is likely to be. The present approach relies upon 
the judgment of the therapist about the most reasonable number and placement of temperature 
probes for sampling of tumor temperature within clinical constraints. We believe that this will 





A potential limitation of the present algorithm is that it does require that the multiplexed power 
sources are non-interfering. For certain microwave systems, the assumption of linear 
combination of SAR sources will be false. It remains for the algorithm to be tested with different 
sources to determine the extent of this limitation. Additional computer simulations using the 
three dimensional bio-heat equation are also in order to further define the limitations of the 
algorithm. Most important are studies of the effects of the location of temperature sensors and of 
more complex geometries, especially situations in which extensive normal tissue intervenes 
between power applicators and tumor tissues. 
 
Nevertheless, future implementation of control algorithms of this type, in conjunction with a 
multi-applicator hyperthermia systems, may lead both to a lower incidence of complications 
caused by hot spots within the treatment field and to a lower incidence of treatment failures 
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